Comparison of estrogen receptor DNA binding in untreated and acquired antiestrogen-resistant human breast tumors

Cancer Research

Volumn 57, Issue 17, 1997, Pages 3723-3727

  Johnston, Stephen R D ^a   Lu, B ^b   Dowsett, Mitchell ^a   Liang, X ^b   Kaufmann, Manfred ^c,e   Scott, Gary K ^b   Osborne, C Kent ^d   Benz, Christopher C ^b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTROGEN RECEPTOR; TAMOXIFEN;

ARTICLE; BREAST TUMOR; COMPARATIVE STUDY; COMPLEX FORMATION; DNA BINDING; DNA SEQUENCE; ELECTROPHORETIC MOBILITY; GENE TARGETING; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN PROCESSING; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; DNA, NEOPLASM; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MICE; MICE, NUDE; RECEPTORS, ESTROGEN; TAMOXIFEN; TRANSCRIPTION FACTORS;

EID: 0030819407     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. McGuire, W. L. Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin. Oncol., 5: 428-433, 1978.
2. McGuire, W. L. Steroid hormone receptors in breast cancer treatment strategy. Recent Prog. Horm. Res., 36: 135-156, 1980.
3. Scott, G. K., Kushner, P., Vigne, J-L., and Benz, C. C. Truncated forms of DNA-binding estrogen receptor. J. Clin. Invest., 88: 700-706, 1991.
4. Montgomery, P. A., Scott, G. K., Luce, M. C., Kaufmann, M., and Benz, C. C. Human breast tumors containing non-DNA-binding immunoreactive (67-kDa) estrogen receptor. Breast Cancer Res. Treat., 26: 181-189, 1993.
5. Spataro, V., Price, K., Goldhirsch, A., Cavalli, F., Simoncini, E., and Castiglioni, M. Sequential estrogen receptor determinations from primary breast cancer and at relapse: prognostic and therapeutic relevance. Ann. Oncol., 3: 733-740, 1992.
6. Kuukasjärvi, T., Kononen, J., Helin, H., Holli, K., and Isola, J. Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy. J. Clin. Oncol., 14: 2584-2589, 1996.
7. Johnston, S. R. D., Saccani-Jotti, G., Smith, I. E., Salter, J., Newby, J., Coppen, M., Ebbs, S. R., and Dowsett, M. Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer. Cancer Res., 55: 3331-3338, 1995.
8. Howell, A., DeFriend, D., and Anderson, E. Mechanisms of response and resistance to endocrine therapy for breast cancer and the development of new treatments. Endocr. Rel. Cancer, 43: 5-21, 1993.
9. Osborne, C. K., Hobbs, K., and Clark, G. M. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res., 45: 584-590, 1985.
10. Osborne, C. K., Coronado-Heinsohn, E. B., Hilsenbeck, S. G., McCue, B. L., Wakeling, A. E., McClelland, R. A., Manning, D. L., and Nicholson, R. I. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer. J. Natl. Cancer Inst., 87: 746-750, 1995.
11. Greene, G. L., Sobel, N. B., King, W. J., and Jensen, E. V. Immunochemical studies of estrogen receptors. J. Steroid Biochem., 20: 51-56, 1984.
12. Detre, S., King, N., Salter, J., MacLennan, K., McKinna, J. A., and Dowsett, M. Immunohistochemical and biochemical analysis of the estrogen-regulated protein pS2, and its relation with estrogen receptor and progesterone receptor in breast cancer. J. Clin. Pathol. (Lond.), 47: 240-244, 1994.
13. Hamada, K., Gleason, S. L., Levi, B-Z., Hirschfeld, S., Appella, E., and Ozato, K. H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen response element. Proc. Natl. Acad. Sci. USA, 86: 8989-8293, 1989.
14. Osborne, C. K., Elledge, R. M., and Fuqua, S. A. W. Estrogen receptors in breast cancer therapy. Sci. Med., 3: 32-41, 1996.
15. Fuqua, S. A. W., Fitzgerald, S. D., Chamness, G. C., Tandon, A. K., McDonnell, D. P., Nawaz, Z., O'Malley, B. W., and McGuire, W. L. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res., 51: 105-109, 1991.
16. Daffada, A. A. I., Johnston, S. R. D., Smith, I. E., Detre, S., King, N., and Dowsett, M. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer. Cancer Res., 55: 288-293, 1995.
17. Dowsett, M., Daffada, A. A. I., Chan, C. M. W., and Johnston, S. R. D. Estrogen receptor mutants and variants in breast cancer. Eur. J. Cancer, in press, 1997.
18. Foster, B. D., Cavener, D. R., and Parl, F. F. Binding analysis of the estrogen receptor to its specific DNA target site in human breast cancer tissue. Cancer Res., 51: 3405-3410, 1991.
19. Taylor, R. E., Powles, T. J., Humphreys, J., Bettelheim, R., Dowsett, M., Casey, A. J., Neville, A. M., and Coombes, R. C. Effects of endocrine therapy on steroid receptor content of breast cancer. Br. J. Cancer, 45: 80-85, 1982.
20. Hull, D. F., Clark, G. M., Osborne, C. K., Chamness, G. C., Knight, W. A., and McGuire, W. L. Multiple estrogen receptor assays in human breast cancer. Cancer Res., 43: 413-416, 1983.
21. Encarnacion, C. A., Ciocca, D. R., McGuire, W. L., Clark, G. M., Fuqua, S. A., and Osborne, C. K. Measurement of steroid hormone receptors in breast cancer patients on tamoxifen. Breast Cancer Res. Treat., 26: 237-246, 1993.
22. Osborne, C. K. Heterogeneity in hormone receptor status in primary and metastatic breast cancer, Semin. Oncol., 12: 317-326, 1985.
23. Gottardis, M., and Jordan, V. C. Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration. Cancer Res., 48: 5183-5187, 1988.
24. Gottardis, M. M., Jiang, S-Y., Jeng, M-H., and Jordan, V. C. Inhibition of tamoxifen-stimulaled growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens. Cancer Res., 49: 4090-4093, 1989.
25. Webb, P., Lopez, G. N., Uht, R. M., and Kushner, P. J. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol. Endocrinol., 9: 443-456, 1995.